Aprotinin and renal dysfunction: the role of exposure to angiotensin-converting enzyme inhibitors.
Augoustides
John G T
JG
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D007611:Aprotinin / Q000009:adverse effects* / Q000627:therapeutic use; D015331:Cohort Studies; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods*; D023921:Coronary Stenosis / Q000175:diagnosis / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D011182:Postoperative Care; D011183:Postoperative Complications / Q000188:drug therapy; D011379:Prognosis; D051437:Renal Insufficiency / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D007611:Aprotinin